Necrobiosis lipoidica diabeticorum

Necrobiosis lipoidica diabeticorum is the indication for 6 drugs in DrugBank. It is covered by 6 curated, structured indications.

Classified under: Digestive System Diseases
Endocrine System Diseases
Nutritional and Metabolic Diseases
Signs, Symptoms, and General Pathologies
Skin and Subcutaneous Tissue Diseases
Vascular Diseases
Indicated drugs: Betamethasone
Betamethasone phosphate
Bupivacaine
Dexamethasone
Methylprednisolone
Triamcinolone

Resolves to

Vocabularies

MeSHM0542821SNOMED CT56391002MedDRA10056969UMLSC0392445

What you can answer from here — as of October 21, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

1Clinical trialPhase, status and sponsor resolved per trial

Which approved drugs for Necrobiosis lipoidica diabeticorum share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.